Supplementary Figure S2 from Targeted Therapy of TERT-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy Jingwei Chen , Christopher Nelson , Matthew Wong , Andrew E. Tee , Pei Y. Liu , Ting La , Jamie I. Fletcher , Alvin Kamili , Chelsea Mayoh , Christoph Bartenhagen , Toby N. Trahair , Ning Xu , Nisitha Jayatilleke , Marie Wong , Hui Peng , Bernard Atmadibrata , Belamy B. Cheung , Qing Lan , Tracy M. Bryan , Pieter Mestdagh , Jo Vandesompele , Valerie Combaret , Valentina Boeva , Jenny Y. Wang , Isabelle Janoueix-Lerosey , Mark J. Cowley , Karen L. MacKenzie , Alla Dolnikov , Jinyan Li , Patsie Polly , Glenn M. Marshall , Roger R. Reddel , Murray D. Norris , Michelle Haber , Matthias Fischer , Xu D. Zhang , Hilda A. Pickett , Tao Liu openalex（2023）
Key words
Neuroblastoma, BET Bromodomains, Therapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
